Medlive Technology Co., Ltd. (HKG:2192)
Hong Kong · Delayed Price · Currency is HKD 7.80
+0.18 (2.36%)
Jul 31, 2026, 4:08 PM HKT
Medlive Technology Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5,773 | 7,138 | 7,270 | 6,165 | 6,119 | 19,400 | |
Market Cap Growth | -51.67% | -1.81% | 17.93% | 0.75% | -68.46% | - |
Enterprise Value | 1,705 | 3,251 | 3,186 | 1,443 | 1,384 | 19,201 |
Last Close Price | 7.80 | 9.50 | 9.51 | 7.86 | 7.72 | 24.56 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 15.45 | 19.19 | 21.68 | 23.09 | 46.14 | 389.12 |
Forward PE | 14.81 | 18.19 | 24.68 | 47.25 | 45.73 | 6.21 |
PS Ratio | 8.08 | 9.99 | 12.23 | 13.58 | 17.24 | 55.56 |
PB Ratio | 1.05 | 1.30 | 1.41 | 1.21 | 1.22 | 3.98 |
P/TBV Ratio | 1.12 | 1.39 | 1.49 | 1.28 | 1.27 | 4.08 |
P/FCF Ratio | 42.15 | 52.12 | 70.90 | 55.34 | 71.37 | 372.18 |
P/OCF Ratio | 38.56 | 47.68 | 63.07 | 54.93 | 70.12 | 355.69 |
PEG Ratio | - | 0.51 | 0.51 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.39 | 4.55 | 5.36 | 3.18 | 3.90 | 55.00 |
EV/EBITDA Ratio | 8.28 | 16.70 | 24.81 | 19.01 | 19.84 | 245.44 |
EV/EBIT Ratio | 9.16 | 17.46 | 25.49 | 20.16 | 20.47 | 253.93 |
EV/FCF Ratio | 12.45 | 23.74 | 31.07 | 12.96 | 16.15 | 368.37 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
Debt / EBITDA Ratio | 0.05 | 0.05 | 0.17 | 0.11 | 0.17 | 0.20 |
Debt / FCF Ratio | 0.08 | 0.08 | 0.24 | 0.08 | 0.15 | 0.31 |
Net Debt / Equity Ratio | -0.75 | -0.75 | -0.85 | -0.95 | -0.95 | -0.98 |
Net Debt / EBITDA Ratio | -21.25 | -21.25 | -34.23 | -63.81 | -68.21 | -61.20 |
Net Debt / FCF Ratio | -30.21 | -30.21 | -42.86 | -43.49 | -55.51 | -91.85 |
Asset Turnover | 0.13 | 0.13 | 0.11 | 0.09 | 0.07 | 0.13 |
Inventory Turnover | - | - | - | 1078.32 | 691.56 | - |
Quick Ratio | 19.05 | 19.05 | 20.89 | 24.04 | 32.74 | 35.42 |
Current Ratio | 19.09 | 19.09 | 21.04 | 24.10 | 32.78 | 35.45 |
Return on Equity (ROE) | 7.11% | 7.11% | 6.95% | 5.55% | 3.01% | 2.19% |
Return on Assets (ROA) | 2.04% | 2.04% | 1.47% | 0.86% | 0.86% | 1.77% |
Return on Invested Capital (ROIC) | 13.37% | 16.72% | 23.44% | 27.58% | 38.18% | 92.12% |
Return on Capital Employed (ROCE) | 3.40% | 3.40% | 2.40% | 1.40% | 1.30% | 1.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 6.44% | 5.21% | 4.61% | 4.33% | 2.17% | 0.26% |
FCF Yield | 2.37% | 1.92% | 1.41% | 1.81% | 1.40% | 0.27% |
Dividend Yield | 3.87% | 3.04% | 2.88% | 3.24% | 0.96% | 0.08% |
Payout Ratio | 55.50% | 55.50% | 56.81% | 51.46% | 10.34% | 226.51% |
Buyback Yield / Dilution | -0.07% | -0.07% | -0.23% | 0.26% | -15.84% | -18.82% |
Total Shareholder Return | 3.81% | 2.98% | 2.65% | 3.50% | -14.88% | -18.74% |